PXM

4-(AMINOMETHYL)-5-(HYDROXYMETHYL)-2-METHYLPYRIDIN-3-OL

Created: 2003-11-13
Last modified:  2020-06-05

Find related ligands:

Chemical Details

Formal Charge0
Atom Count24
Chiral Atom Count0
Bond Count24
Aromatic Bond Count6
2D diagram of PXM

Chemical Component Summary

Name4-(AMINOMETHYL)-5-(HYDROXYMETHYL)-2-METHYLPYRIDIN-3-OL
SynonymsPYRIDOXAMINE
Systematic Name (OpenEye OEToolkits)4-(aminomethyl)-5-(hydroxymethyl)-2-methyl-pyridin-3-ol
FormulaC8 H12 N2 O2
Molecular Weight168.193
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04Oc1c(c(cnc1C)CO)CN
SMILESCACTVS3.341Cc1ncc(CO)c(CN)c1O
SMILESOpenEye OEToolkits1.5.0Cc1c(c(c(cn1)CO)CN)O
Canonical SMILESCACTVS3.341 Cc1ncc(CO)c(CN)c1O
Canonical SMILESOpenEye OEToolkits1.5.0 Cc1c(c(c(cn1)CO)CN)O
InChIInChI1.03 InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3
InChIKeyInChI1.03 NHZMQXZHNVQTQA-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB11673 
NamePyridoxamine
Groups investigational
DescriptionPyridoxamine has been used in trials studying the treatment of Kidney Stones.
Synonyms
  • Pyridoxamine hydrochloride
  • Pyridoxamine phosphate
  • Pyridoxamine
Categories
  • Micronutrients
  • Picolines
  • Pyridines
  • Vitamin B Complex
  • Vitamins
CAS number85-87-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Advanced glycosylation end product-specific receptorMAAGTAVGAWVLVLSLWGAVVGAQNITARIGEPLVLKCKGAPKKPPQRLE...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 11205997, 1052
ChEMBL CHEMBL593019
ChEBI CHEBI:16410